abstract |
The invention relates to transdermal systems for the delivery of clonidine, which are characterized in that the clonidine is in a pressure-sensitive adhesive layer based on a 2-ethylhexyl acrylate-vinyl acetate copolymer, and their use for the treatment of hypertension, migraines, anxiety, hyperkinetic behavior disorders, withdrawal symptoms Alcohol or drug withdrawal and menopausal symptoms. |